F3Logic’s West Pharmaceutical WST Stock Holding History

F3Logic’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,270	Closed	-$1.35M	–	245
2022 Q1	$1.35M	Sell	3,270 -4,116	-56%	-$1.61M	0.2%	65
2021 Q4	$3.34M	Buy	7,386 +9	+0.1%	+$3.87K	0.39%	51
2021 Q3	$3.14M	Sell	7,377 -425	-5%	-$179K	0.41%	42
2021 Q2	$2.8M	Buy	7,802 +1,071	+16%	+$354K	0.34%	57
2021 Q1	$1.89M	Buy	+6,731	New	+$1.93M	0.27%	72

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

F3Logic's WST Position: Q2 2022 in Review

F3Logic sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 3,270 shares — an estimated $1.35M sold.

F3Logic first reported a position in WST in Q1 2021 and held it in 5 quarters. The position peaked at $3.34M in Q4 2021. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

F3Logic reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
F3Logic sold 3,270 West Pharmaceutical shares in Q2 2022, an estimated $1.35M.
F3Logic first reported a position in West Pharmaceutical in Q1 2021 and held it in 5 quarters.
F3Logic's West Pharmaceutical position peaked at $3.34M in Q4 2021.
655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on F3Logic's 13F filing for Q2 2022, filed 3 Aug 2022.